Details
Stereochemistry | ACHIRAL |
Molecular Formula | 3C6H4NO2.Cr |
Molecular Weight | 418.3005 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cr+3].[O-]C(=O)C1=NC=CC=C1.[O-]C(=O)C2=NC=CC=C2.[O-]C(=O)C3=NC=CC=C3
InChI
InChIKey=CBDQOLKNTOMMTL-UHFFFAOYSA-K
InChI=1S/3C6H5NO2.Cr/c3*8-6(9)5-3-1-2-4-7-5;/h3*1-4H,(H,8,9);/q;;;+3/p-3
Chromium sulfate(III) hexahydrate or chromium sulphate, a trivalent compound of chromium that was investigated as a toxic compound. Experiments on rodent have shown chromium sulfate produced severe and widespread effects in the nasal cavity, larynx, lungs, and mediastinal lymph node. Effects were characterized by the accumulation of foreign material, infiltration of alveolar macrophages, septal cell hyperplasia, and granulomatous and chronic inflammation. Besides, chromium sulphate exerted a disadvantageous effect on the skeleton, as it decreases bone density and resistance.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0004714 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15924436 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | CHROMIUM Approved UseChromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. Launch Date2005 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
41 (Number of products:6537)
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
||
|
FDA ORPHAN DRUG |
456814
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
||
|
DSLD |
2491 (Number of products:132)
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
S71T8B8Z6P
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
1133638
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
14639-25-9
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
C28931
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
50369
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
SUB127351
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
DB11255
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
SUB13363MIG
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
m3510
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000090351
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
4511
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
15713-60-7
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
ALTERNATIVE | |||
|
S71T8B8Z6P
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
Chromium(III) picolinate
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
151932
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
DTXSID1024831
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
59308
Created by
admin on Fri Dec 15 15:43:05 GMT 2023 , Edited by admin on Fri Dec 15 15:43:05 GMT 2023
|
PRIMARY | RxNorm |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD